Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY, USA.
Vet Clin Pathol. 2020 Jun;49(2):249-257. doi: 10.1111/vcp.12843. Epub 2020 Apr 4.
Flow cytometry (FC) is used increasingly in veterinary medicine for further characterization of hematolymphoid cells. Guidelines for optimizing assay performance and interpretation of results are limited, and concordance of results across laboratories is unknown.
This study aimed to determine inter-investigator agreement on the interpretation of FC results from split samples analyzed in different laboratories using various protocols, cytometers, and software; and on the interpretation of archived FC standard (FCS) data files contributed by the different investigators.
This was a multicenter observational cross-sectional study. Anticoagulated blood or lymph node aspirate samples from nine client-owned dogs were aliquoted and shipped to participating laboratories. Samples were analyzed with individual laboratory-developed protocols. In addition, FCS files from a set of separate samples from 11 client-owned dogs were analyzed by participating investigators. A person not associated with the study tabulated the results and interpretations. Agreement of interpretations was assessed with Fleiss' kappa statistic.
Prolonged transit times affected sample quality for some laboratories. Overall agreement among investigators regarding the FC sample interpretation was strong (κ = 0.86 ± 0.19, P < .001), and for specific categories, ranged from moderate to perfect. Agreement of the lymphoproliferation or other leukocyte sample category from the analysis of the FCS files was weak (κ = 0.58 ± 0.05, P < .001).
Lymphoproliferations were readily identified by FC, but identification of the categories of hematolymphoid neoplasia in fresh samples or archived files was variable. There is a need for a more standardized approach to maximize the enormous potential of FC in veterinary medicine.
流式细胞术(FC)在兽医领域越来越多地用于进一步描述血液淋巴样细胞。用于优化检测性能和解释结果的指南有限,并且实验室之间的结果一致性尚不清楚。
本研究旨在确定在不同实验室中使用不同方案、细胞仪和软件分析分割样本时,对 FC 结果的解释在不同研究者之间的一致性;并确定不同研究者提供的存档流式细胞术标准(FCS)数据文件的解释的一致性。
这是一项多中心观察性横断面研究。将抗凝血液或淋巴结抽吸样本从 9 只患犬的样本中取出并分发给参与研究的实验室。使用各实验室自行开发的方案对样本进行分析。此外,还分析了 11 只患犬的一组单独样本的 FCS 文件。一名与研究无关的人员对结果和解释进行了制表。采用 Fleiss'kappa 统计评估解释的一致性。
一些实验室的样本运输时间过长影响了样本质量。研究人员之间对 FC 样本解释的总体一致性较强(κ=0.86±0.19,P<0.001),对于特定类别,范围从中度到完美。对 FCS 文件分析中淋巴细胞增多或其他白细胞样本类别的解释一致性较弱(κ=0.58±0.05,P<0.001)。
通过 FC 可以很容易地识别淋巴细胞增多,但在新鲜样本或存档文件中识别血液淋巴样肿瘤的类别存在差异。需要采用更标准化的方法来最大程度地发挥 FC 在兽医领域的巨大潜力。